Chapter 388 Traditional Chinese Medicine Begins to Take Effect

The emergence of two medicines, "999 Cold Granules" and "Children's Cough Syrup", quickly captured the market, and the situation of supply exceeding demand was eye-catching.

This achievement not only marks that the hard work of the Liujiazhuang Institute of Traditional Chinese Medicine, led by famous Chinese medicine experts and professors from medical universities, has finally paid off, but also puts an end to the long-standing controversy in Liujiazhuang.

It also allowed the third uncle Liu Yuanhai and the village committee leaders who firmly supported Liu Zhiye's decision to finally feel relieved.

Their persistence and faith have finally paid off. Their prestige in the hearts of the villagers has risen, consolidating their solid position in the subdistrict office.

Once upon a time, the leadership of Liujiazhuang was criticized by some villagers who were unaware of the situation because of its huge investment in traditional Chinese medicine.

Some cadres of the newly merged villages have privately complained about this, believing that such huge investment for many consecutive years with no output has been a huge economic burden, and that it may not be wise to do so.

However, with the successful launch of these two drugs and the enthusiastic response they triggered in the market, all doubts and confusions disappeared.

The Liujiazhuang Pharmaceutical Factory had only been in operation for more than half a year, and its only two products were "999 Cold Relief Granules" and "Children's Cough Syrup", but it had successfully entered the domestic pharmaceutical field.

Due to the limited production capacity in the early stage, the market quickly faced a tense situation of insufficient supply of medicines. Especially as winter deepened, the number of cold and fever cases increased sharply, and the demand rose sharply.

Hospitals, schools, factories, enterprises, institutions and even supply and marketing cooperatives and medical systems have sent out fleets of cars to pick up goods at the Liujiazhuang Pharmaceutical Factory, creating a spectacular scene.

A tense atmosphere permeates the production line. As soon as the newly-produced medicines are packed, they are loaded onto trucks and shipped to various locations to meet urgent demands.

In just half a year, the "Liujiazhuang Pharmaceutical Factory" has produced medicines worth up to 1.85 million yuan and paid 3700 million yuan in profits and taxes, thanks to its hot-selling performance, with remarkable results.

You should know that during this period, the Northeast Sixth Pharmaceutical Factory, which was listed as one of the top ten pharmaceutical factories in the country, had an annual output value of nearly 2000 million yuan and paid more than million yuan in profits and taxes each year.

In just six months, the annual output value of "Liujiazhuang Pharmaceutical Factory" has surpassed the long-established Northeast Sixth Pharmaceutical Factory and jumped to the seventh place in the list of the top ten pharmaceutical companies in Xia Country. This achievement is remarkable.

It is particularly worth mentioning that this pharmaceutical factory is not only the only local enterprise representative on the list, but also stands out among many state-owned pharmaceutical giants and shines alone.

Its rise has undoubtedly injected a strong breath of fresh blood into the entire pharmaceutical industry, and has also made people inside and outside the industry take a new look at this emerging force.

Since the day it became famous, "Liujiazhuang Pharmaceutical Factory" has welcomed waves of inspections from senior leaders and won countless praises.

Looking into the future, the factory is expected to become a leading enterprise in the Liujiazhuang area, and the realization of this goal is just around the corner.

The success of these two medicines not only brought unprecedented honor and economic benefits to Liujiazhuang, but also allowed the villagers to witness the unlimited potential and broad prospects of traditional Chinese medicine.

Today, there is harmony in Liujiazhuang, and the discordant voices of the past have completely become a thing of the past.

The brilliant achievements of these two medicines have undoubtedly injected new vitality into the cause of traditional Chinese medicine and paved a more solid path for the future development of Liujiazhuang.

The outstanding results of "999 Cold Relief Granules" and "Children's Cough Syrup" not only made Liujiazhuang's unknown folk Chinese medicine research institute famous and won wide recognition from all walks of life, but also made it an honor to receive personal praise from the big boss in charge of health education.

After Liu Zhiye came back and learned this great news, he finally felt relieved.

When Liu Zhiye returned and heard this exciting news, the heavy weight in his heart instantly disappeared.

He had never expected that the Institute of Traditional Chinese Medicine would be so efficient and quickly transform the research ideas he had submitted to researchers into tangible results. This surprise far exceeded his imagination.

In the vast ocean of medicine, every research is no joke. It is often accompanied by huge economic investment and scientific research efforts, which are not easily undertaken by ordinary companies or local governments.

This success not only demonstrated the strong strength of the Institute of Traditional Chinese Medicine, but also made Liu Zhiye deeply feel the heavy sense of accomplishment and pride in the road of scientific research.

Over the years, Liu Zhiye has been silently supporting the cultivation and planting of traditional Chinese medicine in Liujiazhuang. Whenever there is a good harvest of medicinal materials, he is the most solid backing, purchasing large quantities to ensure that Liujiazhuang's hard work is rewarded.

However, with the passage of time, the quality of Liujiazhuang's traditional Chinese medicine has been improving day by day, and finally won the favor and praise of many medical and health departments including Union Hospital.

This change, like a gentle spring breeze, quietly changed the fate of Liujiazhuang's traditional Chinese medicine industry.

Liu Zhiye was delighted to see this. He knew very well that it was time to let traditional Chinese medicine on this land thrive on its own.

Therefore, he began to gradually reduce the transfusion to Liujiazhuang's traditional Chinese medicine planting, and instead, with a longer-term vision, increased research in the field of traditional Chinese patent medicine.

Deep processing from raw materials to finished medicines is the ultimate way out for traditional Chinese medicine cultivation.

After the Institute of Traditional Chinese Medicine successfully developed two drugs, researchers gained more confidence.

Today, the institute is bustling with activity, as researchers are intensively engaging in research on more traditional Chinese medicines.

Including "Angong Niuhuang Pills", "Lianhua Qingwen Capsules", "Guipi Pills", "Xiaoyao Pills", "Xuefu Zhuyu Pills", "Shaofu Zhuyu Pills", "Shengmai Yin", "Guizhi Fuling Capsules", "Jieyu Anshen Pills", "Huoluo Xieling Dan", "Xiangsha Yangwei Pills", "Liujunzi Pills", "Qingre Qushi Granules", "Jianpi Pills", "Guilingji", "Yunnan Baiyao", "Anshen Pills", "Shexiang Baoxin Pills", "Babaodan Capsules", "Xinhuang Tablets", "Andolin Capsules", "Shuanglian Oral Liquid" and a series of famous Chinese patent medicines in later generations.

Of course, Liu Zhiye didn't know the formulas of these Chinese patent medicines. Although he knew medical skills, he didn't know how to make medicine.

He didn't even know the prescriptions of these Chinese patent medicines. He had only heard about them from others or had used some of them.

Later, according to data from MinEnet, in the summer of 2023, the sales of traditional Chinese medicines in physical pharmacies in China's cities exceeded 1200 billion yuan.

This year, 220 Chinese patent medicines had sales of over 123 million yuan, of which 77 showed positive growth and 10 showed growth of more than 40%. Among these Chinese patent medicines, were exclusive varieties (including exclusive dosage forms), and companies such as Sinopharm and China Resources all had varieties on the list.

It is particularly noteworthy that Angong Niuhuang Pills, as a Class A national medical insurance product, has become one of the major products worth over 50 billion yuan with its effects of clearing away heat and detoxifying, calming the nerves and invigorating the mind. It is used for emergency treatment of various diseases such as stroke coma, encephalitis, meningitis, toxic encephalopathy, cerebral hemorrhage, sepsis, etc.

In addition, in the summer of 2023, the sales of traditional Chinese medicines for internal use in public medical institutions exceeded 2000 billion yuan, setting a new record... These data reflect the scale and growth of the traditional Chinese medicine market in 2023, as well as the market performance of some key companies.

The field of Traditional Chinese Medicine is like a boundless deep ocean, containing endless mysteries and possibilities. Liujiazhuang's Traditional Chinese Medicine Research Institute must naturally select the essence and work hard in this vast field.

Among the daily needs of the general public, medicines for common diseases such as colds, fever, abdominal pain, diarrhea, and anti-inflammation are undoubtedly the most in demand. These seemingly ordinary minor illnesses are actually related to the health and well-being of thousands of households.

Therefore, the pharmaceutical factory in Liujiazhuang resolutely took the treatment of common diseases such as colds, fevers and pneumonia as the main direction of enterprise development.

Liu Zhiye knows very well that only with precise positioning can he stand out in the fierce market competition in the future and bring safer and more effective treatment options to the majority of patients.

Cold medicines in later generations accounted for a large proportion of the over-the-counter drug market in the Xia Dynasty, far higher than other categories of over-the-counter drugs.

Except for 2021, the market size of OTC cold medicines in the retail terminal market in Xiaguo has shown an overall growth trend. In 2022, the market size reached 415.2 billion yuan, a year-on-year increase of 48%.

According to data from MinEnet, in the retail market of traditional Chinese medicine for colds in 2021, China Resources Sanjiu had a market share of approximately 28%, far higher than other manufacturers.

China Resources Sanjiu's cold medicine brand is highly competitive. According to statistics from the Xiaguo OTC Drug Association, in the comprehensive ranking of Chinese patent medicine products for colds and coughs in 2022, four products of China Resources Sanjiu were among the TOP15, among which "999" Ganmao Ling Granules/Capsules ranked in the top two, with obvious brand advantages.

Master Sun, an employee, witnessed the glory of the "Liujiazhuang Pharmaceutical Factory". The newly produced products "999 Cold Medicine Granules" and "Children's Cough Syrup" occupied a huge share of the national cold medicine market as soon as they were launched on the market.

The Liujiazhuang Pharmaceutical Factory, which has only more than 1000 workers, can generate huge profits by producing only two raw material medicines.

The company made huge profits, and the employees also enjoyed great benefits. The workers' wages increased by 50% for several consecutive months, and various bonus systems were established, which made employees of other companies envious and wanted to transfer to the "Liujiazhuang Pharmaceutical Factory" to work.

The third uncle Liu Yuanhai told Liu Zhiye that many employees were former villagers of Liujiazhuang, and some of the entire family worked in the pharmaceutical factory.

Therefore, this year many villagers' family income has increased by more than double compared to last year.

After suddenly making a lot of money, the pharmaceutical factory did not rest on its laurels, but is actively expanding its production lines and recruiting and training more production workers.

Moreover, for employees from other places, the factory decided to set aside part of its profits and plans to build dormitories for them next year.

Every out-of-town employee can be allocated a nice house, and the pharmaceutical factory also provides employees with many preferential policies for purchasing houses.

This welfare policy has become something that the people of Liujiazhuang Pharmaceutical Factory are particularly proud of. The most common scene at that time was that some non-local employees excitedly discussed their future residences. They could finally settle down in Liujiazhuang, which made non-local employees of other companies envious.

You can easily settle down in Liujiazhuang by purchasing a property. The attractiveness of this policy far exceeds the cumbersome and complicated settlement process in Beijing, and has become the preferred choice for many outsiders.

However, today, it is no longer easy to settle down in Liujiazhuang. Its difficulty even exceeds that of going to Beijing. One can't help but sigh that with the changes in the world, it is becoming more and more difficult for outsiders to settle down.

It is conceivable that the sudden emergence of the new policy of "Liujiazhuang Pharmaceutical Factory" instantly set off a boom in the job market. Applicants flocked to the factory, and the scene was spectacular.

This is not just a job, it is a competition that concerns your family's future life.

Among them, the most attractive is the benefit of buying a house and settling down. This condition is like a magnet, firmly attracting the attention of countless dreamers, making them stand out in this competition at all costs and firmly grasp this seemingly unattainable job opportunity.

For a time, the "Liujiazhuang Pharmaceutical Factory" became the focus of attention of the people in the Beijing area. And this job became the golden key to a better life, making everyone with a dream excited.

…………

By the end of 1965, the population of Liujiazhuang area had jumped to an astonishing 135,000 people.

In this vibrant land, migrant workers and young students constitute a huge group, with their number approaching 100,000. They gather here with their dreams.

In contrast, residents with local household registration are relatively few, accounting for only a quarter of the total population, silently witnessing the increasing prosperity of this land due to the influx of outsiders.

In the Liujiazhuang area of ​​about 300 to 400 square kilometers, the flood of immigrants has become a force that cannot be ignored. They have witnessed and participated in the magnificent chapter of the rise of industry here.

Among the once quiet mountains and fields, there are now modern factories, with machines roaring and lights on, weaving together an industrial miracle that belongs to this land.

At the end of 3.5, the Liujiazhuang area, with only 8.953 local residents and more than 7 floating population, created a gross domestic product of million yuan, with a per capita GDP of nearly yuan.

This data ranks third among all districts and cities in Beijing, and eleventh among county-level administrative units nationwide.

However, Liujiazhuang's per capita GDP ranks first in the country, while the national per capita GDP is less than 300 yuan this year.

Including Liujiazhuang, Beijing's per capita GDP is 1024 yuan, excluding Liujiazhuang, Beijing's GDP is only 680 yuan. Shanghai has the highest per capita GDP, which is only 1240 yuan.

This year, Beijing's economic performance has been impressive, with its gross domestic product firmly above 80 billion yuan, ranking second in the country.

Among them, Liujiazhuang Sub-district Office contributed about 8.8% of the share on its own, demonstrating its important position in the regional economy.

Turning our attention to the whole country, the national GDP in 1798 was 124 billion yuan. Among them, Shanghai is undoubtedly the shining pearl in the economic map of Xia State, with a total GDP of billion yuan, which is far ahead of others.

Among all the districts and counties in Shanghai, Nanhui County also performed well, with a GDP of 13.54 billion yuan. Although it was better than Liujiazhuang Sub-district Office and other areas, it still ranked first.

However, the top 100 economically strong counties in the country are all old economically strong counties that have been discovered over many years. Only the Liujiazhuang area has risen from an ordinary mountain village after only seven or eight years of development.

From the above, we can see that the Liujiazhuang Sub-district Office is now strong in the economic field of Xia State.

The remote mountainous area in the west of Beijing, which was originally a remote place, exists like a corner in the Beijing area. Even the local indigenous people of Beijing have never heard of the name of this place, let alone the Chinese people.

The situation is very different now. With the strong therapeutic effects of "999 Cold Relief" and "Children's Cough Syrup", the mellow flavor of "Wild Mountain Liquor", and the fragrance of "Jingxi Rice", these brands are not only popular all over the country, but have also quietly imprinted the name "Liujiazhuang" deeply in the hearts of all Chinese people.

Over the years, the continuous promotion by official media has been like a spring breeze, allowing the stories and legends of "Liujiazhuang" to cross thousands of mountains and rivers and enter thousands of households.

"The No. 1 Village in China!"

"Ten Thousand Yuan Household Village!"

"The Pearl of Western Beijing!"

"Huaguoshan!"

"Well-off village!"

"Socialist New Countryside!"

…………

Liujiazhuang has won countless praises.

The leadership team of Liujiazhuang, headed by the third uncle Liu Yuanhai, has also won many honors for their outstanding political achievements.

Such as "National Outstanding Communist Party Member", "May 1st Model Worker", "March 8th Red Flag Bearer", "National Advanced Worker", "People's Model", "National Science and Technology Progress Award", "National Moral Model" and other national honorary medals and honors.

Some high-level leaders of the Xia State even wanted Liu Yuanhai to go directly to the State Council to serve as deputy to Mr. Wu.

It’s really enormous wealth!

However, the third uncle Liu Yuanhai knew his own limitations and did not get carried away and agree to the deal without knowing the consequences.

Among the many enterprises developed in Liujiazhuang, the one that Liu Zhiye is most concerned about is the traditional Chinese medicine industry.

He came from the future and was well aware of the brilliant prospects of the biomedical field in the future.

In the future, major global groups and consortiums will flood into this territory full of opportunities and compete to explore the unknown.

High-tech companies are also unwilling to lag behind and have adjusted their course, transforming and venturing into this field, vowing to occupy a place in the wave of biomedicine.

According to data from Frost & Sullivan and China Business Industry Research Institute, the global pharmaceutical market size was US$2021 billion in 14012 and is expected to reach US$2024 billion by 16387.

In 2023, the scale of the Chinese medicine market will account for about 23.7% of the total pharmaceutical industry! The Chinese medicine market is growing rapidly.

This growth trend reflects the continued development and expansion of the global pharmaceutical market.

Traditional Chinese medicine will be a big piece of fat meat in the future. Whoever enters this field earlier will gain the first-mover advantage and be invincible.

Liujiazhuang’s biggest competitor in the future will not be from within the country, but from the Japanese pirates across the sea.

The vigorous development of Japanese traditional Chinese medicine began ten years later in 1976. In that year, the Ministry of Health, Labor and Welfare officially included Kampo medicine in health insurance, and listed the main 210 effective prescriptions and 140 kinds of crude drugs as medical drugs, allowing Kampo medicine to be included in medical insurance.

This policy has greatly encouraged the use of Chinese herbal medicine, and patients only need to bear 10%-30% of the cost.

In addition, the Japanese pirates also attached importance to traditional Chinese medicine education. These measures jointly promoted the development and application of traditional Chinese medicine in Japan.

Prior to this, the use of traditional Chinese medicine among the Japanese pirates was mainly limited to the royal aristocracy and was inaccessible to ordinary civilians.

However, with policy changes, traditional Chinese medicine began to be more widely disseminated and used among the people.

"The positive pole must be negative, the negative pole must be positive, and everything will turn into the opposite extreme."

Perhaps it was for this reason that, after experiencing the highly developed Western medicine, the Japanese pirates discovered the huge flaws of Western medicine and began to pay attention to the traditional Chinese medicine that they had abandoned in the past. This led to the rapid development of traditional Chinese medicine among the Japanese pirates.

Regrettably, when Chinese medicine was developing among the Japanese pirates, it was the day when Chinese medicine in the Xia Dynasty was declining. That was in the 1980s, after the reform and opening up of the Xia Dynasty, some people absorbed a lot of Western ideas, began to worship foreign things and abandoned Chinese medicine. However, it was at this time that the Japanese pirates re-recognized the importance of Chinese medicine.

So that...

(End of this chapter)